Addressing Challenges in Managing AL Amyloidosis with Cardia

Faculty delve into potential challenges related to the management of patients with AL amyloidosis and cardiac involvement, discussing the associated prognostic implications.

Related Keywords

, Transforming Outcomes , Precision Medicine , Targeted Therapies , Light Chain Amyloidosis , Al Amyloidosis , Andromeda , Daratumumab , Vital , Pronto , Affirm Al , Nexicart 1 , Amyloid Deposits , Cd 38 Directed Monoclonal Antibodies , Cardiac Involvement , Mayo Cardiac Staging , Stem Cell Transplant , Remission , Duration Of Therapy , Diagnosis , Unmet Needs , Managing Al Amyloidosis , Treating Al Amyloidosis , Nxc 201 , Cart Therapy , Amyloidosis Diagnosis , Prognosis , Mortality ,